11.57
Finanzdaten der Vir Biotechnology Inc-Aktie (VIR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
824.05K%
238.95
|
-0.029 | 64.07 | 0.24 | 1.214 |
| Cost Of Revenue |
-
|
- | - | - | 0.011 |
|
|
29.38%
30.20
|
23.34 | - | - | - |
| Costs And Expenses |
25.12%
165.48
|
132.26 | 111.99 | 173.68 | 119.63 |
| Operating Income/Loss |
155.53%
73.47
|
-132.29 | -47.92 | -173.44 | -118.42 |
| Nonoperating Income/Loss |
0.40%
6.792
|
6.765 | 4.861 | 10.47 | 7.629 |
| Income/Loss From Continuing Operations Before Tax |
163.94%
80.26
|
-125.53 | -43.06 | -162.97 | -110.79 |
| Income Tax Expense/Benefit |
5.29%
0.179
|
0.17 | -0.137 | 0.168 | 0.17 |
| Net Income/Loss |
163.71%
80.08
|
-125.69 | -42.92 | -163.14 | -110.96 |
| Basic Average Shares |
13.82%
167.72
|
147.36 | 0.2329 | 138.93 | 138.45 |
| Diluted Average Shares |
14.61%
168.88
|
147.36 | 0.2329 | 138.93 | 138.45 |
| Basic Earnings Per Share |
156.47%
0.48
|
-0.85 | -0.30 | -1.17 | -0.80 |
| Diluted Earnings Per Share |
155.29%
0.47
|
-0.85 | -0.30 | -1.17 | -0.80 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):